Middletown, DE -- (SBWIRE) -- 09/18/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Glu Mobile Inc.(NASDAQ:GLUU), GT Advanced Technologies Inc(NASDAQ:GTAT), Array Biopharma Inc(NASDAQ:ARRY), RR Donnelley & Sons Co(NASDAQ:RRD)
Glu Mobile Inc.(NASDAQ:GLUU) was a volume gainer of 1.78 million shares and the average volume of the stock remained 1.47 million shares. The stock opened the session at $2.12 and finished at the end of the day at $2.18 and the stock escalated +2.83%.The market capitalization of the stock remained 153.77 million. The half-yearly trend of the stock remained negative -34.73%. Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the users of smartphones and tablet devices. The company develops games based on its own brands, including Blood & Glory, Big Time Gangsta, Contract Killer, Contract Killer: Zombies, Deer Hunter, Eternity Warriors, Frontline Commando, Gun Bros, Samurai vs.
For How Long GLUU will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, GT Advanced Technologies Inc (NASDAQ:GTAT) exchanged 1.73 million shares and the average volume remained 4.31 million shares. The stock closed the session at $6.89 with the gain of +2.38%. Tracking three months and 6 months trends, the stock was at of +82.76% and +136.69%, respectively. GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide. The company operates through three segments: Polysilicon; Photovoltaic (PV); and Sapphire.
Will GTAT Continue To Move Higher? Find Out Here
Array Biopharma Inc(NASDAQ:ARRY) enhanced +2.13% and its closing price was $6.23. The volume of the stock was 1.72 million shares and the average volume remained 1.55 million shares. Yesterday, the stock traded amid the day price range of $6.06 - $6.23. The market capitalization of the stock remained 729.02 million. The beta of the stock remained 1.75. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific. Its proprietary clinical programs include ARRY-520.
Why Should Investors Buy ARRY After The Recent Gain? Just Go Here and Find Out
RR Donnelley & Sons Co(NASDAQ:RRD) exchanged 1.68 million shares in the previous trading session, and its average trading remained 2.25 million shares. RRD advanced +1.04% and it closed the trading at $16.57. The market capitalization of the stock remained 3.01 billion. YTD trend of the stock was positive +85.97%. R.R. Donnelley & Sons Company provides integrated communication solutions to private and public sectors worldwide. The company offers label and paperboard packaging products, as well as prime label, corrugated, and other packaging products.
For How Long RRD’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)